title: Functional significance of using tissue adhesive substance in nephron-sparing surgery: assessment by quantitative SPECT of 99m Tc-Dimercaptosuccinic acid scintigraphy.
abstract: OBJECTIVE
  To compare changes in renal function following nephron-sparing surgery (NSS) using tissue adhesive only versus NSS using standard suturing technique, as measured by quantitative SPECT of 99m Tc-dimercaptosuccinic acid uptake by the kidney (QDMSA).
  
  
  METHODS
  QDMSA was done before and 3-6 mo after the operation in 32 patients who underwent standard suturing technique and in 24 patients in whom tissue adhesive sealant (19 with albumin glutaraldehyde tissue adhesive [BioGlue]; 5 with CoSeal) was used to close the parenchymal defect. Individual kidney uptake was measured and retrospectively compared between the two groups.
  
  
  RESULTS
  Average tumor diameter was 3.4cm (range: 2.2-6) in the suture group and 3.56 (range: 1.7-6) in the tissue sealant group. In the tissue sealant group following surgery, we observed an average individual renal function loss of 11.49% compared with the suture group in whom an average individual renal function loss of 20.36% (p = 0.02) was measured by 99m Tc-DMSA.
  
  
  CONCLUSIONS
  The use of tissue sealant to close the parenchymal defect during NSS demonstrated a statistically significant advantage in reducing functioning renal loss as measured by the absolute uptake of QDMSA. Further clinical studies are required to establish the role of tissue sealants in NSS.
authors.affiliation: Department of Urology, Bnai-Zion and Medical Center, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. guy@hidas.net
authors.forename: Guy
authors.initials: G
authors.lastname: Hidas
authors.forename: Liad
authors.initials: L
authors.lastname: Lupinsky
authors.forename: Alexander
authors.initials: A
authors.lastname: Kastin
authors.forename: Boaz
authors.initials: B
authors.lastname: Moskovitz
authors.forename: David
authors.initials: D
authors.lastname: Groshar
authors.forename: Ofer
authors.initials: O
authors.lastname: Nativ
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000379:methods*; D009399:Nephrons / Q000000981:diagnostic imaging / Q000378:metabolism / Q000601:surgery; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011506:Proteins / Q000494:pharmacology*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012189:Retrospective Studies; D013536:Suture Techniques; D019783:Technetium Tc 99m Dimercaptosuccinic Acid / Q000493:pharmacokinetics; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D016896:Treatment Outcome
chemical_list: C472676:Bio-glue; C513322:CoSeal; D011506:Proteins; D019275:Radiopharmaceuticals; D011092:Polyethylene Glycols; D019783:Technetium Tc 99m Dimercaptosuccinic Acid